Hepatic failure due to hepatitis B reactivation in a patient with ulcerative colitis treated with prednisone

✍ Scribed by Jonas Zeitz; Beat Mullhaupt; Heiko Fruehauf; Gerhard Rogler; Stephan R. Vavricka

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 53 KB
• Volume: 50
• Category: Article
• ISSN: 0270-9139
• DOI: 10.1002/hep.23035

✦ Synopsis

tumors only for the involved lobe? Because Table 1 states that 90 patients had a tumor burden of less than 50%, this would have been possible just to prevent too much damage to the uninvolved liver. Other investigators have found for transarterial chemoembolization that intra-arterial hepatic regional therapies can be safely performed in the presence of partial portal vein occlusion if a modified, low-dose, superselective or segmental technique is used. 2,3 What was done if there was stasis in the injected artery before all the yttrium was injected, or did this never happen?

There are some minor points as well. Table 2 states that 20 of 30 patients with portal vein thrombosis had a tumor burden greater than 50% and 10 patients had a tumor burden greater than or equal to 50%. Because only 14 patients were graded Okuda II and 2 patients were graded Okuda III, should I suppose that this is a misspelling and that the tumor burden was less than 50% in 20 patients? In addition, in Table 1, should I suppose that the number of patients without portal vein thrombosis was 71 and not (as stated) only 1?